P11-4 and Nanosilver Fluoride Varnish in Treatment of White Spot Carious Lesions
Effectiveness of Self-assembling Peptide (P11-4) and Nano-silver Fluoride Varnish in Management of Enamel White Spot Lesions in Young People (Randomized Controlled Clinical Trial)
1 other identifier
interventional
66
1 country
1
Brief Summary
Background: Great efforts have been undertaken for dental caries prevention. Among the recent remineralizing materials, Nano silver fluoride varnish products which are based on nanotechnology have been proposed for "repairing" enamel . Regenerative medicine-based approaches for caries treatment focus on biomimetic remineralization of initial carious lesions as a minimal invasive therapy using Self-Assembling Peptide P11-4 (Curodont Repair) which enhances remineralization of white spot lesions. Purpose of the Study: The aim of this study is to compare clinically and microbiologically the therapeutic effect of Self Assembling Peptide P11-4 (Curodont Repair), nano silver fluoride varnish and 5% fluoride varnish (Duraflor) on remineralization of enamel White Spot Lesions in permanent teeth of adults.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 5, 2020
CompletedFirst Submitted
Initial submission to the registry
June 15, 2021
CompletedFirst Posted
Study publicly available on registry
June 18, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 5, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2022
CompletedJune 18, 2021
June 1, 2021
10 months
June 15, 2021
June 15, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Change in the activity status of lesions scored using ICDAS-LAA
Change in the activity status of lesions scored using ICDAS-LAA from baseline to final follow up.
12 months
Secondary Outcomes (2)
Change in mean DIAGNOdent readings.
12 months
Microbial count of mutans streptococci, lactobacilli.
6 months
Study Arms (3)
self-assembling peptide (P11-4)
EXPERIMENTALCurodont Repair; Credentis will be applied to the white spot lesion at baseline.
nanosilver fluoride varnish
ACTIVE COMPARATOR(Study group) Nano-silver fluoride varnish will be applied to the white spot lesion at baseline.
sodium fluoride varnish
PLACEBO COMPARATOR(Control group) Fluoride varnish (Duraflor) will be applied to the white spot lesion at baseline and 6 months follow up.
Interventions
each Curodont Repair applicator unit contains both Curolox technology for guided enamel regeneration and water for activation of the device, each box contains 10 applicators
The synthesis of aqueous solution of silver nanoparticles will be carried out via the chemical reduction of silver nitrate (1 mL, 0.11 M) with sodium borohydride (0.3 mL, 0.8 M) and chitosan biopolymer (28.7 mL, 2.5 mg/mL) as a stabilizing agent. Sodium fluoride (10,147 ppm of fluorine) will be incorporated at the end of the experiment.
5% sodium fluoride varnish; One ml of fluoride varnish contains 50 mg of sodium fluoride in an alcohol-based suspension of resins.
Eligibility Criteria
You may qualify if:
- An age range of 10-24 years ( age of young adolescents and youth as described by the WHO was selected (WHO, 2019). 2. The presence of at least one visible WSL in the buccal surface of permanent teeth with ICDAS II score of 1, or 2. 3. Completion of an informed consent to participate in the study
You may not qualify if:
- \. Patients receiving the following medications: tetracyclines, any other medication known to stain teeth or any medication causing dry mouth and/or limiting salivary flow. 2. Patients receiving any antibiotic within 1 month prior to each saliva sample collection 3. Selected tooth with microcavities or dentinal involvement due to loss of enamel tissues. 4. Selected tooth with a restoration adjacent to the lesions to avoid false- positive readings. 5. Selected tooth with fluoride application \< 3 months prior to study treatment. 6. Selected tooth with discolouration, enamel hypoplasia or fluorosis. 7. Patients with multiple cavitations to avoid variability in microbiological analysis.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculty of dentistry
Alexandria, Egypt
Related Publications (2)
Atteya SM, Amer HA, Saleh SM, Safwat Y. The effect of nano silver fluoride, self-assembling peptide and sodium fluoride varnish on salivary cariogenic bacteria: a randomized controlled clinical trial. Clin Oral Investig. 2024 Feb 23;28(3):167. doi: 10.1007/s00784-024-05562-0.
PMID: 38388987DERIVEDAtteya SM, Amer HA, Saleh SM, Safwat Y. Self-assembling peptide and nano-silver fluoride in remineralizing early enamel carious lesions: randomized controlled clinical trial. BMC Oral Health. 2023 Aug 19;23(1):577. doi: 10.1186/s12903-023-03269-4.
PMID: 37598194DERIVED
MeSH Terms
Interventions
Study Officials
- STUDY DIRECTOR
Hala A Amer, PHD
Alexandria University
- PRINCIPAL INVESTIGATOR
Susan M Saleh, PHD
Alexandria University
- PRINCIPAL INVESTIGATOR
Yara S Selim, PHD
Alexandria University
- PRINCIPAL INVESTIGATOR
Sara M Atteya, PHD
Alexandria University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Assistant lecturer
Study Record Dates
First Submitted
June 15, 2021
First Posted
June 18, 2021
Study Start
December 5, 2020
Primary Completion
October 5, 2021
Study Completion
January 1, 2022
Last Updated
June 18, 2021
Record last verified: 2021-06